Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Craniopharyngioma
100%
Radiotherapy
75%
Gross Total Removal
75%
Tumor
50%
10-year Follow-up
50%
Cyst
50%
Evacuation
50%
Partial Removal
50%
Visual Field Defect
50%
Obesity
25%
Endocrinology
25%
Natural History
25%
Treatment Outcome
25%
Between-group
25%
Epilepsy
25%
Clinical Features
25%
Survival Rate
25%
Large Series
25%
Primary Surgery
25%
Surgical Intervention
25%
Adult Life
25%
Diabetes Insipidus
25%
Tumor Regrowth
25%
Postoperative Mortality
25%
Hydrocephalus
25%
First Year
25%
Headache
25%
Median Time
25%
Unfavorable Prognosis
25%
Hyperphagia
25%
Tumor-associated
25%
Natural Treatment
25%
Adult-onset
25%
Recurrence-free Survival
25%
Adjuvant Radiotherapy
25%
Pituitary Hormones
25%
Childhood-onset
25%
Nontumor
25%
Re-accumulation
25%
Optimal Treatment
25%
10-year Survival
25%
TSH Deficiency
25%
Histological Appearance
25%
Endocrinological
25%
First Recurrence
25%
Pediatric Clinics
25%
Preclinical Imaging
25%
Monoparesis
25%
Primary Intracranial Tumours
25%
Cyst Fluid
25%
Medicine and Dentistry
Neoplasm
100%
Craniopharyngioma
100%
Recurrent Disease
80%
Radiation Therapy
60%
Evacuation
40%
Survival Rate
40%
Visual Field Defect
40%
Endocrinology
20%
Intracranial Tumor
20%
Pediatrics
20%
Clinical Feature
20%
Minoxidil
20%
Surgical Mortality
20%
Corticotropin
20%
Headache
20%
Recurrence Free Survival
20%
Follitropin
20%
Adjuvant Radiotherapy
20%
Hydrocephalus
20%
Hypophysis Hormone
20%
Polyphagia
20%
Clinical Imaging
20%
Diabetes Insipidus
20%
Cyst Fluid
20%
Neuroscience
Craniopharyngioma
100%
Radiation Therapy
100%
Visual Field Defect
50%
Hydrocephalus
25%
Adrenocorticotropic Hormone
25%
Endocrinology
25%
Minoxidil
25%
Hypophysis Hormone
25%
Headache
25%
Intracranial Tumor
25%
Polyphagia
25%
Diabetes Insipidus
25%
Follicle-Stimulating Hormone
25%